Myocardial infarction

Lore & Background

Myocardial infarction occurs most commonly due to coronary artery disease, with the underlying mechanism being the complete blockage of a coronary artery caused by rupture of an atherosclerotic plaque. Less common causes include coronary artery spasms from cocaine, significant emotional stress (Takotsubo syndrome), or extreme cold. The most common symptom is retrosternal chest pain that may radiate to the left shoulder, arm, or jaw, and can feel like heartburn. Women more often present without chest pain, instead having neck pain, arm pain, or fatigue. Among those over 70–75 years old, about 5% have had an MI with little or no history of symptoms.

Reader's Guide

Myocardial infarction is a critical medical emergency requiring time-sensitive treatment. Diagnosis is aided by electrocardiograms (ECGs), which can confirm ST elevation MI (STEMI) if ST elevation is present, and blood tests such as troponin. Treatment for STEMI focuses on restoring blood flow via percutaneous coronary intervention (PCI) or thrombolysis. Non-ST elevation MI (NSTEMI) is often managed with heparin and PCI in high-risk cases. Long-term management includes lifestyle modifications, aspirin, beta blockers, and statins. Worldwide, about 15.9 million MIs occurred in 2015, with STEMIs occurring about twice as often in men as women. In the developed world, the risk of death after a STEMI is about 10%.

Did You Know?

• Silent myocardial infarctions, which occur without any symptoms, represent between 22 and 64% of all infarctions.
• Women more often present without chest pain and instead have neck pain, arm pain, or feel tired.
• An MI may cause heart failure, an irregular heartbeat, cardiogenic shock, or cardiac arrest.
• STEMIs occur about twice as often in men as women.

The Silent Mechanism Behind the Event

A myocardial infarction is, at its core, a catastrophic failure of oxygen delivery to the heart muscle. When a coronary artery becomes occluded, the downstream tissue is starved of the oxygen it needs to survive, and within minutes that muscle begins to die. In the vast majority of cases, the culprit is atherosclerotic disease: a hardened plaque within the arterial wall ruptures, triggering a complete blockage that cuts off blood flow. This distinguishes a true infarction from unstable angina, where blood flow is compromised but no permanent cell death occurs. Less frequently, the artery simply spasms shut, a reaction that can be provoked by cocaine use, intense emotional stress (the phenomenon popularly called Takotsubo or broken heart syndrome), or even exposure to extreme cold. The consequences of that tissue death cascade rapidly. The damaged muscle can no longer contract effectively, setting the stage for heart failure, dangerous arrhythmias, cardiogenic shock, or outright cardiac arrest. Unlike cardiac arrest, where the heart stops beating altogether, an infarction is the upstream event that may ultimately precipitate that final, fatal rhythm.

A Spectrum of Warning Signs

The classic textbook description of a heart attack centers on a deep, crushing pressure behind the breastbone that radiates into the left arm, jaw, or neck. In reality, the presentation is far more variable. The pain may feel like a burning, a tearing sensation, or even an overwhelming sense of impending doom rather than discrete discomfort. It typically persists beyond twenty minutes and does not shift with body position. Some patients describe it as indistinguishable from heartburn. Beyond the chest, the body may respond with cold sweats, nausea, dizziness, and a general sense of fatigue. Women, in particular, are more likely to present without the hallmark chest pain, instead reporting neck discomfort, arm aches, unusual tiredness, or unexplained nausea. Among adults over seventy, roughly five percent experience an infarction with virtually no warning symptoms at all. Because of this variability, clinicians rely on a combination of tools: an electrocardiogram to detect characteristic ST-segment elevation, blood tests measuring troponin levels to confirm actual muscle cell death, and coronary angiography to visualize the blocked vessel directly.

The Race Against Time in Treatment

Every minute of delayed reperfusion means more heart muscle dies, which is why managing a suspected infarction is treated as a true emergency. The first intervention a bystander or paramedic can offer is aspirin, which helps prevent the clot from growing. Nitroglycerin and opioid analgesics may ease the chest pain, though neither has been shown to improve long-term survival. For patients with low oxygen saturation or significant breathing difficulty, supplemental oxygen is added. The definitive step depends on the ECG findings. In a ST-elevation infarction, the goal is to reopen the blocked artery as quickly as possible, either through percutaneous coronary intervention—mechanically pushing the vessel open and placing a stent—or through thrombolysis, where clot-dissolving drugs are administered intravenously. Non-ST-elevation cases are often managed with heparin, reserving interventional procedures for those at higher risk. When multiple coronary arteries are diseased and the patient also has diabetes, surgeons may recommend bypass grafting rather than angioplasty. After survival, the long-term regimen typically includes daily aspirin, a beta blocker, and a statin, paired with meaningful lifestyle changes.

A Global and Economic Weight

The sheer scale of myocardial infarction is staggering. In 2015 alone, an estimated 15.9 million events occurred worldwide, with more than three million classified as ST-elevation infarctions and over four million as non-ST-elevation events. The condition does not affect all groups equally: ST-elevation infarctions occur roughly twice as often in men as in women, and the United States alone sees approximately one million infarctions every year. In developed nations, the mortality risk following an ST-elevation event hovers around ten percent, a figure that underscores how much has been achieved in acute care while still highlighting the lethality of the condition. Encouragingly, age-adjusted rates of infarction declined globally between 1990 and 2010, reflecting progress in prevention and treatment. Yet the economic toll remains enormous. In 2011, myocardial infarction ranked among the five most costly inpatient conditions in the United States, accounting for roughly $11.5 billion across 612,000 hospital stays—a reminder that the burden extends far beyond the individual patient to the healthcare systems that must absorb it.

Gallery